Project BioShield Act:

HHS Has Supported Development, Procurement, and Emergency Use of Medical Countermeasures to Address Health Threats

GAO-09-878R: Published: Jul 24, 2009. Publicly Released: Jul 24, 2009.

Additional Materials:

Contact:

Cynthia A. Bascetta
(202) 512-7207
contact@gao.gov

 

Office of Public Affairs
(202) 512-4800
youngc1@gao.gov

This report formally transmits the briefing in response to section 247d-6c of title 42 of the United States Code. The statute required the Comptroller General to examine the Department of Health and Human Services' (HHS) support for the development and procurement of and authority for the emergency use of medical countermeasures to address chemical, biological, radiological, and nuclear threats to public health, and provide the results to the congressional committees by July 21, 2009.

HHS determines priorities for medical countermeasure procurement based on those chemical, biological, radiological, and nuclear agents that have been identified by the Department of Homeland Security as posing a material threat to the U.S. population that could affect national security.

Apr 28, 2016

Apr 19, 2016

Apr 18, 2016

Apr 14, 2016

Apr 13, 2016

Mar 17, 2016

Mar 10, 2016

Looking for more? Browse all our products here